Integer Holdings Co. (NYSE:ITGR) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. lowered its position in Integer Holdings Co. (NYSE:ITGR) by 1.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 175,362 shares of the medical equipment provider’s stock after selling 3,306 shares during the period. Principal Financial Group Inc. owned about 0.52% of Integer worth $22,797,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Earnest Partners LLC lifted its holdings in shares of Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after buying an additional 37,340 shares during the period. Geode Capital Management LLC lifted its holdings in Integer by 1.2% in the third quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock valued at $99,408,000 after acquiring an additional 9,421 shares during the period. Loomis Sayles & Co. L P boosted its position in shares of Integer by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after purchasing an additional 15,446 shares in the last quarter. Congress Asset Management Co. grew its stake in shares of Integer by 3.9% during the 3rd quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider’s stock worth $63,542,000 after purchasing an additional 18,303 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in Integer by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider’s stock worth $52,524,000 after buying an additional 4,946 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Price Performance

Integer stock opened at $134.75 on Thursday. The company has a market cap of $4.52 billion, a price-to-earnings ratio of 41.59, a PEG ratio of 2.02 and a beta of 1.12. The firm has a 50 day moving average price of $134.43 and a 200 day moving average price of $126.45. Integer Holdings Co. has a 1 year low of $94.56 and a 1 year high of $142.76. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.27 earnings per share. Sell-side analysts predict that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

ITGR has been the topic of a number of research reports. Piper Sandler restated an “overweight” rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. Citigroup raised their price target on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Bank of America increased their price objective on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. KeyCorp upped their price target on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $145.44.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.